Xu, B., Liang, X., Liu, W., Wu, B., Wang, Q., Kai, G., . . . Wang, L. EPHX1 enhances drug resistance to regorafenib by activating the JAK/STAT signaling pathway in hepatocellular carcinoma cell lines. BMC.
Chicago Style (17th ed.) CitationXu, Bin, et al. EPHX1 Enhances Drug Resistance to Regorafenib by Activating the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma Cell Lines. BMC.
MLA (9th ed.) CitationXu, Bin, et al. EPHX1 Enhances Drug Resistance to Regorafenib by Activating the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma Cell Lines. BMC.
Warning: These citations may not always be 100% accurate.